Market Cap 26.86B
Revenue (ttm) 3.81B
Net Income (ttm) -644.79M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 174.54
Profit Margin -16.92%
Debt to Equity Ratio 0.05
Volume 389,900
Avg Vol 482,604
Day's Range N/A - N/A
Shares Out 98.69M
Stochastic %K 63%
Beta 0.65
Analysts Strong Sell
Price Target $316.92

Latest News on ONC

BeiGene, Ltd. (ONC) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 10:24 AM EST - 5 weeks ago

BeiGene, Ltd. (ONC) Q4 2024 Earnings Call Transcript


BeiGene to Present at Upcoming Investor Conferences

Feb 25, 2025, 6:01 AM EST - 5 weeks ago

BeiGene to Present at Upcoming Investor Conferences


3 Biotech Stocks With Notable Insider Buying

Jan 22, 2025, 12:29 PM EST - 2 months ago

3 Biotech Stocks With Notable Insider Buying

AUPH AZN COGT JAZZ XBI ZYME


BeiGene Announces Global Licensing Agreement for MAT2A Inhibitor

Dec 12, 2024, 7:30 PM EST - 3 months ago

BeiGene Announces Global Licensing Agreement for MAT2A Inhibitor


Labcorp CFO Glenn Eisenberg Announces Plans to Retire

Nov 19, 2024, 7:00 AM EST - 4 months ago

Labcorp CFO Glenn Eisenberg Announces Plans to Retire

LH


BeiGene Mourns Death of Beloved Board Member Donald Glazer

Oct 28, 2024, 6:00 AM EDT - 5 months ago

BeiGene Mourns Death of Beloved Board Member Donald Glazer


BeiGene Announces Updates to Commercial Leadership Team

Sep 9, 2024, 7:00 AM EDT - 7 months ago

BeiGene Announces Updates to Commercial Leadership Team


Top 2 Health Care Stocks That May Plunge In August

Aug 26, 2024, 7:53 AM EDT - 7 months ago

Top 2 Health Care Stocks That May Plunge In August

HALO


BeiGene: Poised For Re-Rating As BTKi Sales Show Strong Beat

Aug 22, 2024, 10:36 AM EDT - 8 months ago

BeiGene: Poised For Re-Rating As BTKi Sales Show Strong Beat